Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Dicerna Pharmaceuticals, Inc. (DRNA)

« Back to company index

DRNA Chatter Timeline

Stock Ticker for DRNA

Most Active Tweeters for DRNA

UserTweets
@Tickeron 7
@FlashAlert_me 5
@humour_humourrr 4
@mediasentiment 3
@StockTexts 3

Recent Tweets for DRNA

mediasentiment @mediasentiment
$DRNA new alert at https://t.co/A7qrDaJkzw #stocks #daytrading #NYSE #NASDAQ #market 1002
April 19th 2021, 11:04pm
mediasentiment @mediasentiment
$DRNA new alert at https://t.co/A7qrDaJkzw #stocks #daytrading #NYSE #NASDAQ #market 964
April 19th 2021, 8:04pm
humour_humourrr @humour_humourrr
$DRNA unbelievably strong in current small cap biotech tape. I guess whoever wanted to exit did so at $20 or below. https://t.co/drbBeXJr78
April 19th 2021, 4:04pm
Tickeron @Tickeron
$DRNA's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this… https://t.co/yokeU1pNEr
April 18th 2021, 10:04am
Jarvis_Alerts @Jarvis_Alerts
$DRNA [Dicerna Pharmaceuticals]: Goldman Sachs Initiates Coverage On Buy Announces Price Target $48 https://t.co/pdZY9VQTdY
April 17th 2021, 8:04am
Tickeron @Tickeron
$DRNA's in Uptrend: Moving Average Convergence Divergence (MACD) Histogram just turned positive. View odds for this… https://t.co/7OkVP6PDBZ
April 17th 2021, 4:04am
MarcJacksonLA @MarcJacksonLA
$DRNA Goldman Sachs Initiates Coverage On Dicerna Pharmaceuticals With A Buy Rating, $48 PT https://t.co/N7Jcab26HK
April 16th 2021, 1:04pm
Jarvis_Alerts @Jarvis_Alerts
$DRNA (Dicerna Pharmaceuticals): Goldman Sachs Initiates Coverage On Buy 'Announces' Price Target $48 https://t.co/zho5nqpPfc
April 16th 2021, 10:04am
stockhoot @stockhoot
$DRNA Goldman Sachs Initiates Coverage On to Buy : PT $48.00 https://t.co/YxUWL00Oy5
April 16th 2021, 10:04am
sbwcws @sbwcws
Dicerna initiated with a Buy at Goldman Sachs $DRNA
April 16th 2021, 8:04am
CashFlow_Fool @CashFlow_Fool
Bought $DRNA (0.05%): added to HSA account & will add over time; another play on genetic-based medicine but instead… https://t.co/57uCdPcwGE
April 14th 2021, 2:04pm
Tickeron @Tickeron
$DRNA's 10-day Moving Average crossed below its 50-day Moving Average on March 26, 2021. View odds for this and oth… https://t.co/sHijyQg3Ci
April 14th 2021, 4:04am
mediasentiment @mediasentiment
$DRNA new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 844
April 13th 2021, 11:04pm
humour_humourrr @humour_humourrr
@sonichedgefund @mikegoodma I think they will recognize $180M in Q1 per latest 8-K $DRNA https://t.co/vgTSmBHOMO
April 13th 2021, 4:04pm
ShortAlgoKing @ShortAlgoKing
$DRNA Waiting for buy signal. https://t.co/SI5wH2Z0TH
April 13th 2021, 2:04pm
mikegoodma @mikegoodma
At end of 2020 $DRNA had $568.8m in cash. It expects its balance sheet to remain strong due to product revs, paymen… https://t.co/DdJso9Enjo
April 13th 2021, 1:04pm
SwingTradeBot @SwingTradeBot
$DRNA technical alerts: Pocket Pivot, 50 DMA Resistance, Hammer Candlestick, 20 DMA Support, and ... https://t.co/SvLQTafHg8
April 13th 2021, 12:04pm
Tickeron @Tickeron
$DRNA in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/QOZ5aG0L4M
April 13th 2021, 6:04am
EdgarInsider @EdgarInsider
Alert [Press/News Current Report] / Form 8-K filed with the SEC $DRNA Dicerna Pharmaceuticals Inc https://t.co/xLlVo6NiSt
April 12th 2021, 9:04pm
FlashAlert_me @FlashAlert_me
$DRNA [15s. delayed] filed form 8-K on April 12, 17:16:27: Item1.01: Entry into a Material Definitive Agreement https://t.co/OyWp5bmTCl
April 12th 2021, 9:04pm
TradeWithAlerts @TradeWithAlerts
Large Print $DRNA Size: 266036 Price: 26.18 Time: 1600 Amount: $6,964,822.48
April 12th 2021, 8:04pm
Tickeron @Tickeron
$DRNA in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/g5GCa5tfJk
April 12th 2021, 8:04am
Tickeron @Tickeron
$DRNA in Uptrend: Stochastic indicator sits in overbought zone for 2 days. View odds for this and other indicators:… https://t.co/vnehYLcR8p
April 9th 2021, 12:04pm
humour_humourrr @humour_humourrr
$DRNA Company gets $180m cash influx and pps is up few cents ? That's all you need to know about current tape in small cap biotech.
April 8th 2021, 6:04pm
stockhoot @stockhoot
$DRNA SVB Leerink Maintains to Outperform : PT $44.00 https://t.co/9jDUhhrU6t
April 8th 2021, 5:04pm
SmallCapsDaily @SmallCapsDaily
$DRNA Royalty Pharma Acquires OXLUMO Royalty Interest From Dicerna for up to $240 Million GlobeNewswire… https://t.co/VsBJUMWt1i
April 8th 2021, 3:04pm
humour_humourrr @humour_humourrr
@happyycamperr Exactly. It would have taken them years anyway to collect ~$200m from ALNY. $DRNA
April 8th 2021, 12:04pm
happyycamperr @happyycamperr
$DRNA great sale of royalty on Lumasiran for 180MM plus additional milestones.....put the money to work on higher… https://t.co/uGVy5UPnUl
April 8th 2021, 12:04pm
NewsQuantified @NewsQuantified
$DRNA today announced that Royalty Pharma has acquired Dicerna’s royalty interest in OXLUMO™ (lumasiran) for an upf… https://t.co/QJJh1XctyQ
April 8th 2021, 12:04pm
Rickpilk @Rickpilk
Dicerna's $DRNA sale of the royalty interests for one its drugs together with Dicerna’s cash, cash equivalents, inv… https://t.co/GlIINwAQHq
April 8th 2021, 11:04am
otcdynamics @otcdynamics
$DRNA Dicerna Sells OXLUMO™ (lumasiran) Royalty Interest to Royalty Pharma for Up to $240 Million https://t.co/w5JwVHlMuK
April 8th 2021, 11:04am
FlashAlert_me @FlashAlert_me
$DRNA [15s. delayed]: Issued Press Release on April 08, 07:30:00: Dicerna Sells OXLUMO™ (lumasiran) Royalty Interes… https://t.co/iWGXOawjXl
April 8th 2021, 11:04am
Tickeron @Tickeron
$DRNA in Uptrend: Stochastic indicator is remaining in overbought zone for 1 day. View odds for this and other indi… https://t.co/8gzeAPn4IS
April 8th 2021, 7:04am
choochloves10x @choochloves10x
mRNA tech is going to be a miracle wasted on the anti-vaxers. Long $DRNA. https://t.co/z4NmYHhZ4V
April 6th 2021, 4:04pm
InsiderAlerts4U @InsiderAlerts4U
$DRNA: New Insider Filing on Dicerna Pharmaceuticals Inc's Chief Human Resources Officer REGINA M. PAGLIA: https://t.co/JHOeRTXT11
April 6th 2021, 1:04pm
newsfilterio @newsfilterio
Form 4/A (statement of changes in beneficial ownership of securities) filed with the SEC $DRNA https://t.co/kbwKIHVuX5
April 6th 2021, 4:04am
newsfilterio @newsfilterio
Form 4/A (statement of changes in beneficial ownership of securities) filed with the SEC $DRNA https://t.co/ytuNzhyzpC
April 6th 2021, 3:04am
newsfilterio @newsfilterio
Form 4/A (statement of changes in beneficial ownership of securities) filed with the SEC $DRNA https://t.co/hOYCdCWbHy
April 6th 2021, 3:04am
formwhisperscom @formwhisperscom
#FWSells $DRNA Brown Bob D, Chief Scientific Ofr., EVP R&D of Dicerna Pharmaceuticals Inc sold 8,312 shares on 2021… https://t.co/wqyvPVAnGj
April 6th 2021, 3:04am
insiderbuyings @insiderbuyings
$DRNA new insider selling: 8312 shares. https://t.co/ekM2hv6N69
April 6th 2021, 2:04am
StockTexts @StockTexts
$DRNA Dicerna Pharmaceuticals, Inc. SEC Filing: Form 4/A https://t.co/q5WozoglAy
April 6th 2021, 1:04am
fintel_io @fintel_io
Insider Bob D Brown reports selling 8,312 shares of $DRNA for a total cost of $215,025.46 https://t.co/glLrpbIqBp
April 6th 2021, 1:04am
FlashAlert_me @FlashAlert_me
$DRNA [15s. delayed] filed SEC form 4/A: Chief Scientific Ofr., EVP R&D Brown Bob D: Converted securities 8,312 of… https://t.co/5Bi78ZQVh6
April 6th 2021, 1:04am
StockTexts @StockTexts
$DRNA Dicerna Pharmaceuticals, Inc. SEC Filing: Form 4/A https://t.co/RdQiW99e3W
April 6th 2021, 1:04am
FlashAlert_me @FlashAlert_me
$DRNA [15s. delayed] filed SEC form 4/A: Chief Scientific Ofr., EVP R&D Brown Bob D: Converted securities 16,630 o… https://t.co/d4axmAF92w
April 6th 2021, 1:04am
StockTexts @StockTexts
$DRNA Dicerna Pharmaceuticals, Inc. SEC Filing: Form 4 https://t.co/IJ0qgyGx8V
April 6th 2021, 1:04am
FlashAlert_me @FlashAlert_me
$DRNA [15s. delayed] filed SEC form 4: Chief Human Resources Officer Paglia Regina M.: Disposed 4,431 of Common St… https://t.co/BzO6Fr6Ash
April 6th 2021, 1:04am
fintel_io @fintel_io
Insider Paglia Regina M. reports selling 4,431 shares of $DRNA for a total cost of $114,563.95 https://t.co/qrW6FAKbEQ
April 6th 2021, 1:04am
formwhisperscom @formwhisperscom
#FWSells $DRNA Paglia Regina M., Chief Human Resources Officer of Dicerna Pharmaceuticals Inc sold 4,431 shares on… https://t.co/VdW7K77OIh
April 6th 2021, 1:04am
Tickeron @Tickeron
$DRNA in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on November 27, 2020. View odds for th… https://t.co/Hr7GBvpspW
April 5th 2021, 11:04am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.